Receive this Monthly Publication in your Inbox

    Never miss the latest in Healthcare Performance Insider by subscribing HERE!

    @Copyright 2019 - Healthcare Performance Insider a publication from Accumen, Inc

    Where should we send your newsletter?

    Privacy Policy: We hate spam and promise to keep your email address safe


    The Future of Imaging: Assessing the early impacts of COVID-19 and the path to innovation through Artificial Intelligence (AI) A conversation with Dr. Geoff Rubin

    Global Impact: Rebecca Rock, RN and SABM CFO talks with HPI about two roles across two countries

    From Lab Trend Visionary to Dark Group CEO: HPI connects with the Founder and Editor of the Dark Report, Robert Michel

    Two Imaging Leaders, Two Systems, One Outcome: Communication

    From Communication Strength to Just in Time Reopening at MGH A conversation with Dr. James Brink, Chief of Radiology at Massachusetts General Hospital

    From Time Magazine to PBM Influencer: Sherri Ozawa's Mission to Define the Value of Blood

    Buried Blessings: Pandemic perspective from Tom Strauss, CEO at Sisters of Charity Health System

    Katie Castree, Career Healthcare Process Improvement Connoisseur

    Solving Lab Challenges through Recruiting Innovation: HPI connects with Lighthouse Lab Services President, Jon Harol

    Providing Value-Based Care in a Pandemic through Telehealth and Data Resources: An HPI exclusive with Dr. Darrel Weaver

    From Supply Chain Crisis to Innovation in a Pandemic

    From Navy Medic to running a Clinical Laboratory . . . during a pandemic

    Planning for Blood Shortages in a Pandemic with Dr. Claudia Cohn

    Blood Banking is more complex today than ever before. Rob Van Tuyle, President of Vitalant's Blood Division, tells us why.

    Profoundly Impacting Healthcare with Breakthrough Anemia Management

    Supporting Imaging Precisely Where You Need It

    Working Together Makes End of Life Conversations Easier to Have

    The Future of Imaging: Assessing the early impacts of COVID-19 and the path to innovation through Artificial Intelligence (AI) A conversation with Dr. Geoff Rubin

    Pivoting in a Pandemic: How a U.S. 3D printing manufacturer is helping healthcare in its time of need

    Mara G. Aspinall: Diagnostic evangelist educating the world on the power of diagnostics today

    How The Joint Commission is addressing the COVID-19 Pandemic

    CHI Nebraska’s Laboratory Director Connie Wilkins, describes How To Manage a Clinical Laboratory During the pandemic

    Former Commercial Lab Leader Highlights the Hospital Lab as the Solution to Community Sustainability in a Healthcare Crisis

    Three Phases Essential to Crisis Preparedness in Patient Blood Management with Anne Burkey of St. Luke's Health in Boise, ID

    The Importance of Agility in Your Lab

    Dr. Paul Biddinger Shares Three Ways to Prepare for COVID-19

    Bringing Clinical Skills to Operational Leadership During a Time of Crisis; Dr. Blanton, Chief Medical Officer at Peterson Health

    7 Team Attributes to Teams that Work in Challenging Times & Through Rapid Innovation

    From Finding Problems to Saving Lives: The Evolution of Interventional Radiology

    Identifying the Potential with AI in Radiology with Dr. Chung

    Communication in the C-Suite with Cliff Robertson of Catholic Health Initiatives

    Reviewing Your Patient Financial Journey with Melody W. Mulaik, President of Revenue Cycle Coding Strategies

    Ask An Accumen Expert: Carolyn Burns, MD, a Patient Blood Management Advocate

    Linda DeVee, Leads Radiology Services at Edward-Elmhurst Health

    Theresa Mouton, Market Chief Financial Officer with Steward Health

    PELITAS President and CEO Steven Huddleston Wants Patients to Have a Great Experience – Both Clinically and Financially

    How Do You Deal with 2 Billion Forms a Year? Ask Randy Campbell

    Medical Director of Telehealth for UAB Knocks Barriers Down to Treat Patients on Their Terms

    C-Suite Spotlight: Wayne Bohenek Chief Ancillary Services Officer, Bon Secours Mercy Health

    A Leader in the Laboratory Service Line : Pierre Mouawad

    Healthcare Partner: Autumn Farmer, Chief Laboratory Officer, Bon Secours Mercy Health

    How Imbio is using AI to close the gap of missed diagnosis with Mike Hostetler

    Spit Matters with Bill Phillips from Spectrum Solutions

    How COVID-19 inspired TeraRecon to accelerate their imaging solutions to the point of care with Jeff Sorensen

    Dr. Geoff Rubin is a globally recognized Radiologist and thought leader. He has spent the majority of his career building teams at some of the leading education medical centers across the country, including Stanford and Duke Universities. He has been on the forefront of new technologies throughout his career, always believing there is an engineered solution allowing a view into the body without invading the body. As such, he was a pioneer in the use of 3D images to advance diagnosis. Healthcare Performance Insider sat down with Dr. Rubin to gain his insights on the impact of COVID-19 on the Imaging department and the future of innovation in Radiology (specifically AI) given the pandemic.

    COVID-19 Impact on Radiology
    This has been an absolutely profound period of time in terms of the impact that it has had on our delivery of healthcare. One of the many uncertainties is the impact that we have not yet realized. Dr. Rubin hones in on this topic, highlighting several areas he foresees our focus quickly shifting to.

    Unperformed imaging.

    Millions of imaging studies that would have been performed have not been over the last several months. Some of those imaging studies would have been performed on patients undergoing treatment that have serious diseases like cancer. Imaging is used to assess their status and that information has not been available. As we start to open up and those patients come back, hopefully we do not find an overwhelming amount of advanced disease that we didn’t anticipate. Hopefully we don’t find that there are patients who have irreversibly suffered because they were unable to have the benefits of medical imaging.

    Fear of coming to the ED, even in an emergency. There has been an increase in deaths from myocardial infarction and stroke during the course of the COVID-19 pandemic most likely because patients that would have come to the Emergency Department did not come despite concerning symptoms of stroke or heart attack. Patients have concern about being exposed to COVID-19 when seeking health care – an issue that is going to continue to be with us for some time.

    Recovery of substantial financial losses across the spectrum of health care providers. Be it hospitals, physician groups, and other providers in the healthcare value chain, all will continue to feel this strain. It is going to lead to a lot of reflection around how funds are spent moving forward in the pursuit of delivering health care and in advancing our healthcare institutions. There will be a belt tightening and renewed understanding of priorities to provide quality healthcare in this post-COVID environment.

    The new normal is going to be dynamic. Like many, the Imaging environment has a large set of considerations and we are learning as we go. Policies and procedures are critical to assure patient and staff safety as we re-open. Identifying the right configuration of space and technology, personnel availability to ensure social distancing, while bringing the full measure of clinical expertise to the interpretation of imaging studies and performance of image guided procedures will be a new normal.

    We need to be open minded as we reconfigure our departments and workflows. Profitability will come back through the performance of radiology and medical imaging. The pathway for getting there however is to create safe and effective environments so patients can have the imaging procedures that are medically necessary.

    Innovation in a COVID World

    In a pre-COVID world, two letters consumed 90% of any discussion around the future of medical imaging: AI. Physicians and non-clinical consumers alike followed the latest available technologies, trends, and early advancements. Research and investment were synonymous with success and the best wanted to be at the top of both heaps. Enter COVID-19. The work is still there but the focus has shifted – for now. We asked Dr. Rubin to comment on this transition.

    The transformation of imaging through AI

    The transformation of radiology has already begun. From our initial encounter with the patient, to our provision of information to our referring physicians, to the way that information is used, AI offers the opportunity to better understand the value of imaging before imaging is performed. By integrating information from past imaging tests with other health data elements AI may predict the value that performing an imaging test will bring to a specific patient. Additionally, AI will soon be able to integrate image findings with other clinical characteristics to personalize treatment suggestions and predict how a patient might respond to a specific drug or operation in the course of treatment.

    Less really is more

    We already see AI’s remarkable impact in the reconstruction of the images that are being acquired. CT, PET, and MR images have been profoundly influenced by new techniques that allow the images to be reconstructed with a much sparser input of data. These advancements may allow a hospital or imaging center to perform more studies in a shorter period of time, with less patient time on a scanner, potentially less exposure to radiation, and the ability to scan more patients per day.

    AI makes it our way

    New advancements allow for the acquisition of images in a manner that is customized to the specific indications for the imaging, personalizing how the machine is set up – e.g., the parameters for image acquisition, the pulse sequences that are used (in MR) – all depending on the patient’s physical characteristics and health status. AI can separate or “segment” organs and tumors, determining change in characteristics (over time) with greater consistency and higher quality. AI also offers the promise of helping us interpret the acquired images, making preliminary observations to detect urgent conditions and prioritize which exams should be examined first and ensuring that we do not miss subtle findings.

    Given all this, we had to ask: What about the Radiologist?

    Does this all mean that interpreters of medical images will soon be out of a job? Absolutely not. I don’t believe so for a second. I have spent a fair bit of time examining various manifestations of AI, researching it with our teams at Duke. I have an appreciation of the strengths, but also, the weaknesses of leaving decisions to computer models. There is no AI on the horizon that fully replaces human reasoning, our integration and understanding of the nuances in manifestations of disease and associations to uncommon conditions that we encounter. I do think however that AI is going to empower Radiologists to interpret more data within the same amount of time, or quicker, and also provide valuable inferences and observations that are unavailable today.

    Dr. Rubin left us with one more profound thought: Radiologists serve patients through the information that they convey to the physicians who then directly interact with, and treat, the patient. The Radiologist’s responsibility is to empower those physicians, with meaningful imagery, to maximize the value they bring in caring for that patient. It is a significant role in the diagnostic process, using some of the most advanced technology in healthcare today, operating behind the proverbial scenes. We thank Dr. Rubin for bringing his valuable insights into the spotlight here.



    George Barth Geller Distinguished Professor of Cardiovascular Research Professor of Radiology and Bioengineering